Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.
作者信息
Deslée G, Zysman M, Burgel P-R, Perez T, Boyer L, Gonzalez J, Roche N
机构信息
Service de Pneumologie, inserm U1250, CHU Reims, Université Reims Champagne Ardenne, Reims, France.
Service des Maladies Respiratoires, CHU Bordeaux, Univ-Bordeaux, Centre de Recherche cardio-thoracique de Bordeaux, U1045, CIC 1401, Pessac, France.
出版信息
Respir Med Res. 2020 Nov;78:100764. doi: 10.1016/j.resmer.2020.100764. Epub 2020 May 11.
Abstract
摘要
相似文献
1
Chronic obstructive pulmonary disease and the COVID-19 pandemic: Reciprocal challenges.慢性阻塞性肺疾病与新冠疫情：相互挑战
Respir Med Res. 2020 Nov;78:100764. doi: 10.1016/j.resmer.2020.100764. Epub 2020 May 11.
2
Features of severe COVID-19: A systematic review and meta-analysis.严重 COVID-19 的特征：系统评价和荟萃分析。
Eur J Clin Invest. 2020 Oct;50(10):e13378. doi: 10.1111/eci.13378. Epub 2020 Aug 29.
3
Population-based Estimates for High Risk of Severe COVID-19 Disease due to Age and Underlying Health Conditions.基于人群的因年龄和基础健康状况导致的重症 COVID-19 疾病高风险估计。
Acta Med Port. 2020 Nov 2;33(11):720-725. doi: 10.20344/amp.14222. Epub 2020 Jul 24.
4
Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.预测 COVID-19 不良预后的因素：系统评价和荟萃分析。
Eur J Clin Invest. 2020 Oct;50(10):e13362. doi: 10.1111/eci.13362. Epub 2020 Aug 27.
5
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.2020 年 3 月至 4 月，美国北加州非紧急状况下的冠状病毒疾病患者的特征和结局。
Emerg Infect Dis. 2020 Aug;26(8):1679-1685. doi: 10.3201/eid2608.201776. Epub 2020 May 14.
6
Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19.哮喘合并新型冠状病毒肺炎患者住院、重症监护及死亡的危险因素。
J Allergy Clin Immunol. 2020 Oct;146(4):808-812. doi: 10.1016/j.jaci.2020.07.018. Epub 2020 Jul 29.
7
Clinical Characteristics and Outcomes of Patients with Severe COVID-19 and Chronic Obstructive Pulmonary Disease (COPD).严重 COVID-19 和慢性阻塞性肺疾病（COPD）患者的临床特征和结局。
Med Sci Monit. 2020 Sep 4;26:e927212. doi: 10.12659/MSM.927212.
8
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.西班牙一家大学医院中60岁及以上新冠病毒疾病患者的合并症与死亡率
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):756-758. doi: 10.1016/j.arbres.2020.06.012. Epub 2020 Jul 16.
9
Diabetes and covid-19: more than the sum of two morbidities.糖尿病与新冠病毒：不仅仅是两种疾病的叠加。
Rev Saude Publica. 2020;54:54. doi: 10.11606/s1518-8787.2020054002577. Epub 2020 May 29.
10
Asthma and COPD in Hospitalized COVID-19 Patients.住院COVID-19患者中的哮喘和慢性阻塞性肺疾病
Arch Bronconeumol (Engl Ed). 2020 Sep;56(9):604-606. doi: 10.1016/j.arbres.2020.05.007. Epub 2020 May 31.
引用本文的文献
1
Recalibrating Perceptions and Attitudes Toward Nebulizers versus Inhalers for Maintenance Therapy in COPD: Past as Prologue.重新校准慢性阻塞性肺疾病维持治疗中雾化器与吸入器的认知和态度：以史为鉴。
Int J Chron Obstruct Pulmon Dis. 2024 Nov 28;19:2571-2586. doi: 10.2147/COPD.S491275. eCollection 2024.
2
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.评估长期吸入性糖皮质激素治疗对新冠肺炎合并慢性肺部疾病患者的影响：一项多中心回顾性队列研究。
Can J Respir Ther. 2024 Jun 5;60:86-94. doi: 10.29390/001c.118514. eCollection 2024.
3
Application of protection motivation theory in epidemic prevention in patients with respiratory diseases under the COVID-19 pandemic: A cross-sectional study.保护动机理论在 COVID-19 大流行期间呼吸系统疾病患者防疫中的应用：一项横断面研究。
Clin Respir J. 2023 Oct;17(10):1058-1066. doi: 10.1111/crj.13693. Epub 2023 Sep 4.
4
Impact of Coronavirus Disease 2019 on Hospital Admissions, Health Status, and Behavioral Changes of Patients with COPD.2019冠状病毒病对慢性阻塞性肺疾病患者住院情况、健康状况及行为变化的影响
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):211-223. doi: 10.15326/jcopdf.2022.0383.
5
The burden of chronic respiratory disease and attributable risk factors in North Africa and Middle East: findings from global burden of disease study (GBD) 2019.北非和中东地区慢性呼吸道疾病的负担及可归因风险因素：来自全球疾病负担研究（GBD）2019 的调查结果。
Respir Res. 2022 Sep 29;23(1):268. doi: 10.1186/s12931-022-02187-3.
6
Inequity in inequity: Disproportional mortality risk in patients with cancer with COVID-19 in Brazil - a call to action.不平等中的不平等：巴西新冠肺炎合并癌症患者的不成比例死亡风险——行动呼吁
J Geriatr Oncol. 2022 Jul;13(6):885-887. doi: 10.1016/j.jgo.2022.05.003. Epub 2022 May 17.
7
Cross Sectional E-Health Evaluation Study for Telemedicine and M-Health Approaches in Monitoring COVID-19 Patients with Chronic Obstructive Pulmonary Disease (COPD).横断面电子健康评估研究：远程医疗和移动医疗在监测 COVID-19 合并慢性阻塞性肺疾病（COPD）患者中的应用。
Int J Environ Res Public Health. 2021 Aug 12;18(16):8513. doi: 10.3390/ijerph18168513.
8
Eosinophils and Chronic Respiratory Diseases in Hospitalized COVID-19 Patients.住院 COVID-19 患者中的嗜酸性粒细胞与慢性呼吸道疾病。
Front Immunol. 2021 Jun 2;12:668074. doi: 10.3389/fimmu.2021.668074. eCollection 2021.
9
Impact of COVID-19 on COPD and asthma admissions, and the pandemic from a patient's perspective.从患者角度看2019冠状病毒病对慢性阻塞性肺疾病和哮喘住院情况的影响以及疫情
ERJ Open Res. 2021 Feb 8;7(1). doi: 10.1183/23120541.00822-2020. eCollection 2021 Jan.
10
Repurposing Known Drugs as Covalent and Non-covalent Inhibitors of the SARS-CoV-2 Papain-Like Protease.将已知药物重新用作新型冠状病毒木瓜样蛋白酶的共价和非共价抑制剂
Front Chem. 2020 Nov 16;8:594009. doi: 10.3389/fchem.2020.594009. eCollection 2020.
本文引用的文献
1
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病（COVID-19）相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
2
Clinical Characteristics of Covid-19 in New York City.纽约市新冠肺炎的临床特征
N Engl J Med. 2020 Jun 11;382(24):2372-2374. doi: 10.1056/NEJMc2010419. Epub 2020 Apr 17.
3
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响：系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
4
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病（COVID-19）：综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
5
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.吸烟者和 COPD 患者小气道上皮中的 ACE-2 表达：对 COVID-19 的影响。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
6
Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.合并症会增加新冠肺炎患者的风险吗：来自荟萃分析的证据。
Aging (Albany NY). 2020 Apr 8;12(7):6049-6057. doi: 10.18632/aging.103000.
7
Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?慢性呼吸道疾病或其治疗是否会影响感染SARS-CoV-2的风险？
Lancet Respir Med. 2020 May;8(5):436-438. doi: 10.1016/S2213-2600(20)30167-3. Epub 2020 Apr 3.
8
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
9
Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up.2019 年冠状病毒病在老年患者中的特征和预后因素：基于 4 周随访的研究。
J Infect. 2020 Jun;80(6):639-645. doi: 10.1016/j.jinf.2020.03.019. Epub 2020 Mar 30.
10
Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.新冠病毒肺炎住院患者基础疾病的患病率：一项系统评价与Meta分析
Arch Acad Emerg Med. 2020 Mar 24;8(1):e35. eCollection 2020.
Zotero 插件